about
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, inject...
Read More
54.67
-0.56
(-1.01%)
4.7M
XNYS Volume
XNYS 08 Sep, 2025 11:18 AM (EDT)
Medium Financial Strength
Mid Valuation
Technically Bearish
Slowing Down Stock
These stocks score good in Quality and also have medium range financials. However, a bad technical scoring and bearish aspects decrease the investor's interest over time.
View Similar
Embed DVM
Novo Nordisk ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..